Founding Team
Webster Lincoln
Inema Orukari, MD/PhD
Inema Orukari, MD/PhD
Webster Lincoln is the President and CEO with a decade of experience in the biotech field and a background in entrepreneurship. He has worked with major companies such as Genentech, Merck, and the Stanford Research Institute, including supporting collaborations with PathAI. As a data scientist with a background in computer vision, Webster
Webster Lincoln is the President and CEO with a decade of experience in the biotech field and a background in entrepreneurship. He has worked with major companies such as Genentech, Merck, and the Stanford Research Institute, including supporting collaborations with PathAI. As a data scientist with a background in computer vision, Webster has played a significant role in digital pathology and personalized healthcare.
Inema Orukari, MD/PhD
Inema Orukari, MD/PhD
Inema Orukari, MD/PhD
Inema Orukari is the CSO with an MD/PhD and has backgrounds in entrepreneurship, medicine, and engineering. He graduated from Washington University School of Medicine in St. Louis. He has done wide-ranging research in various medical areas and is focused on advancing oncology with personalized treatments. He uses his deep knowledge in quantitative analysis and computer vision in his work.
Advisors
Jon Whiteaker, MS
Jon Whiteaker, MS
Jon Whiteaker, MS
Jon Whiteaker is Head of Engineering at Multiply, a Kleiner Perkins backed Series A startup. With past leadership roles at DoorDash, Square, and Checkr, Jon stands out as a powerhouse in the engineering domain. Beyond his professional pursuits, he's an involved startup advisor and angel investor, all while residing in San Francisco.
Terance Orme, JD
Jon Whiteaker, MS
Jon Whiteaker, MS
Terance Orme, hailing from Richmond, California, brings a distinguished legal background as a Harvard Law School alumnus. His tenure at Foley and Lardner saw him navigate intricate business litigations for Fortune 500 clientele.
Maged Habib, MS
Jon Whiteaker, MS
Pinaki Sarder, PhD
Maged Habib, MSc., brings extensive experience in data engineering from Genentech and histotechnology from Kaiser Permanente and HNL Lab Medicine. He has seamlessly integrated his expertise in bioinformatics and digital pathology, driving innovation and efficiency in clinical laboratory digital solutions.
Pinaki Sarder, PhD
Sajjad M. Malik, MD
Pinaki Sarder, PhD
Dr. Pinaki Sarder is an accomplished associate professor specializing in AI at the University of Florida, focusing on computational health sciences. He has a rich background in electrical engineering and a profound interest in AI applications for kidney disease research and digital pathology. Notably, Dr. Sarder has been continuously fund
Dr. Pinaki Sarder is an accomplished associate professor specializing in AI at the University of Florida, focusing on computational health sciences. He has a rich background in electrical engineering and a profound interest in AI applications for kidney disease research and digital pathology. Notably, Dr. Sarder has been continuously funded by NIH since 2017 as PI of several projects focusing on digital and computational pathology of chronic kidney diseases and acute kidney injury, with federal grant funding awards close to $10M so far.
Anindya Paul, PhD
Sajjad M. Malik, MD
Sajjad M. Malik, MD
Dr. Anindya Paul, PhD, is an AI Scientist with extensive experience in AI for health and medical imaging, specializing in secure, privacy-preserving AI technologies.. His role as an Assistant Scientist at the University of Florida underscores his commitment to advancing AI in healthcare, particularly in transforming patient care through cloud computing and data analytics.
Sajjad M. Malik, MD
Sajjad M. Malik, MD
Sajjad M. Malik, MD
Dr. Sajjad M. Malik, a Drexel University College of Medicine alumnus with specialized training in anatomic and clinical pathology, brings his expertise in oncologic surgical pathology to DigPath. His active role in integrating digital pathology at HNL Lab Medicine demonstrates his commitment to advancing healthcare technologies and aligns with DigPath's vision of revolutionizing digital pathology.